These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37052145)

  • 61. Neurobiological processes in alcohol addiction.
    Lê AD; Kiianmaa K; Cunningham CL; Engel JA; Ericson M; Söderpalm B; Koob GF; Roberts AJ; Weiss F; Hyytiä P; Janhunen S; Mikkola J; Bäckström P; Ponomarev I; Crabbe JC
    Alcohol Clin Exp Res; 2001 May; 25(5 Suppl ISBRA):144S-151S. PubMed ID: 11391064
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence.
    Matzeu A; Terenius L; Martin-Fardon R
    Alcohol Clin Exp Res; 2018 Dec; 42(12):2466-2478. PubMed ID: 30320880
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Imaging corticotropin-releasing-factor and nociceptin in addiction and PTSD models.
    Tollefson S; Himes M; Narendran R
    Int Rev Psychiatry; 2017 Dec; 29(6):567-579. PubMed ID: 29231765
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides.
    Ubaldi M; Bifone A; Ciccocioppo R
    Curr Opin Neurobiol; 2013 Aug; 23(4):684-91. PubMed ID: 23648086
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuropeptides and Addiction: An Introduction.
    Thiele TE
    Int Rev Neurobiol; 2017; 136():1-3. PubMed ID: 29056148
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
    George DT; Gilman J; Hersh J; Thorsell A; Herion D; Geyer C; Peng X; Kielbasa W; Rawlings R; Brandt JE; Gehlert DR; Tauscher JT; Hunt SP; Hommer D; Heilig M
    Science; 2008 Mar; 319(5869):1536-9. PubMed ID: 18276852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Role of endogenous neuropeptides in the pathomechanism of alcohol addiction].
    Rudzińska U; Zalewska-Kaszubska J
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():643-52. PubMed ID: 20097951
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alcohol-related behaviors as models for neuropeptide mediation. Introduction to Part IV.
    Erwin VG
    Ann N Y Acad Sci; 1994 Oct; 739():154-5. PubMed ID: 7832468
    [No Abstract]   [Full Text] [Related]  

  • 69. Effect of ethanol on brain neuropeptides in adolescent and adult rats.
    Slawecki CJ; Jiménez-Vasquez P; Mathé AA; Ehlers CL
    J Stud Alcohol; 2005 Jan; 66(1):46-52. PubMed ID: 15830902
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.
    Bell RL; Hauser S; Rodd ZA; Liang T; Sari Y; McClintick J; Rahman S; Engleman EA
    Int Rev Neurobiol; 2016; 126():179-261. PubMed ID: 27055615
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The neurokinin-1 receptor in addictive processes.
    Schank JR
    J Pharmacol Exp Ther; 2014 Oct; 351(1):2-8. PubMed ID: 25038175
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A neuropeptide-centric view of psychostimulant addiction.
    Boutrel B
    Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sex Differences in the Neurobiology of Alcohol Use Disorder.
    Flores-Bonilla A; Richardson HN
    Alcohol Res; 2020; 40(2):04. PubMed ID: 33042719
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuropeptides and alcohol addiction in monkeys.
    van Ree JM; Kornet M; Goosen C
    EXS; 1994; 71():165-74. PubMed ID: 8032147
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alcoholism and obesity: overlapping neuropeptide pathways?
    Thiele TE; Navarro M; Sparta DR; Fee JR; Knapp DJ; Cubero I
    Neuropeptides; 2003 Dec; 37(6):321-37. PubMed ID: 14698675
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors.
    Sillaber I; Rammes G; Zimmermann S; Mahal B; Zieglgänsberger W; Wurst W; Holsboer F; Spanagel R
    Science; 2002 May; 296(5569):931-3. PubMed ID: 11988580
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dynorphin and its role in alcohol use disorder.
    Karkhanis AN; Al-Hasani R
    Brain Res; 2020 May; 1735():146742. PubMed ID: 32114059
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A role for brain stress systems in addiction.
    Koob GF
    Neuron; 2008 Jul; 59(1):11-34. PubMed ID: 18614026
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacogenetic approaches to the treatment of alcohol addiction.
    Heilig M; Goldman D; Berrettini W; O'Brien CP
    Nat Rev Neurosci; 2011 Oct; 12(11):670-84. PubMed ID: 22011682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.